United States Pharmaceuticals

Verrica Pharmaceuticals Inc (VRCA)

Track

Track

Verrica Pharmaceuticals experienced six insider trading transactions over the past ninety days, all representing open-market purchases. Executives, including the CEO and CFO, acquired shares following a recent earnings report that missed expectations. These acquisitions occurred amid a twenty-one percent decline in stock value, reflecting significant leadership confidence despite current market volatility.
Ticker: VRCA Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Verrica Pharmaceuticals Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.0
Kirby John J. Interim CFO Officer
Transaction date
Purchase
Price
133.11
Quantity 53,630 -47.6%
Value US$1,315,214
1.7
Rosenberg Noah L. CMO Officer
Transaction date
Purchase
Price
213.59
Quantity 81,216 -37.2%
Value US$664,719
Rieger Jayson CEO and President Executive Director
Transaction date
Purchase
Price
467.03
Quantity 82,006 -27.0%
Value US$942,020
1.7
Rosenberg Noah L. CMO Officer
Transaction date
Purchase
Price
4.91
Quantity 4,200 +178.2%
Value US$20,622
Zawitz David Chief Operating Officer Officer
Transaction date
Purchase
Price
4.98
Quantity 6,000 +28.6%
Value US$29,880
Rieger Jayson CEO and President Executive Director
Transaction date
Purchase
Price
5.06
Quantity 20,000 +11.0%
Value US$101,200
Zawitz David Chief Operating Officer Officer
Transaction date
Purchase
Price
4.24
Quantity 10,000 +90.9%
Value US$42,425
3.9
Manning Paul B Non-Executive Director Large shareholder
Transaction date
Purchase
Price
4.24
Quantity 2,750,762 +460.3%
Value US$11,670,108
3.9
Manning Paul B Non-Executive Director Large shareholder
Transaction date
Purchase
Price
4.24
Quantity 1,375,380 +53.3%
Value US$5,835,050
Rieger Jayson CEO and President Executive Director
Transaction date
Purchase
Price
4.24
Quantity 94,311 +106.8%
Value US$400,114
1.0
Kirby John J. Interim CFO Officer
Transaction date
Purchase
Price
4.24
Quantity 3,536 +65.2%
Value US$15,001
1.7
Rosenberg Noah L. CMO Officer
Transaction date
Purchase
Price
4.24
Quantity 2,357 +inf%
Value US$10,000
3.4
Hayes Christopher G. CHIEF LEGAL OFFICER Officer
Transaction date
Sale
Price
0.65
Quantity 4,315 -2.4%
Value US$2,805
2.0
Kohler Terry CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
2.46
Quantity 7,899 -15.0%
Value US$19,432
3.5
Goldenberg Gary Chief Medical Officer Officer
Transaction date
Sale
Price
2.46
Quantity 3,601 -3.7%
Value US$8,858
3.2
White Ted PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
2.46
Quantity 9,021 -4.0%
Value US$22,192
3.4
Hayes Christopher G. CHIEF LEGAL OFFICER Officer
Transaction date
Sale
Price
2.46
Quantity 9,530 -8.3%
Value US$23,444
3.8
Bonaccorso Joe CHIEF COMMERCIAL OFFICER Officer
Transaction date
Sale
Price
2.46
Quantity 8,993 -11.0%
Value US$22,123
2.0
Kohler Terry CHIEF FINANCIAL OFFICER Officer
Transaction date
Sale
Price
2.66
Quantity 21,820 -29.3%
Value US$58,041
3.5
Goldenberg Gary Chief Medical Officer Officer
Transaction date
Sale
Price
2.66
Quantity 9,888 -9.2%
Value US$26,302
3.2
White Ted PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
2.66
Quantity 24,979 -10.0%
Value US$66,444
3.4
Hayes Christopher G. CHIEF LEGAL OFFICER Officer
Transaction date
Sale
Price
2.66
Quantity 26,183 -18.5%
Value US$69,647
3.8
Bonaccorso Joe CHIEF COMMERCIAL OFFICER Officer
Transaction date
Sale
Price
2.66
Quantity 24,709 -23.1%
Value US$65,726
3.4
Hayes Christopher G. Officer Officer
Transaction date
Proposed sale
Price
2.62
Quantity 36,000
Value US$94,300
3.5
Goldenberg Gary Officer Officer
Transaction date
Proposed sale
Price
2.64
Quantity 14,000
Value US$37,000
3.2
White Ted Officer Officer
Transaction date
Proposed sale
Price
2.65
Quantity 34,000
Value US$90,100
3.8
Bonaccorso Joe Officer Officer
Transaction date
Proposed sale
Price
2.65
Quantity 34,000
Value US$90,100
2.0
Kohler Terry Officer Officer
Transaction date
Proposed sale
Price
2.65
Quantity 30,000
Value US$79,500
3.5
Goldenberg Gary Chief Medical Officer Officer
Transaction date
Sale
Price
6.98
Quantity 86 -0.1%
Value US$600
3.8
Bonaccorso Joe CHIEF COMMERCIAL OFFICER Officer
Transaction date
Sale
Price
6.98
Quantity 115 -0.1%
Value US$803
3.4
Hayes Christopher G. CHIEF LEGAL OFFICER Officer
Transaction date
Sale
Price
6.98
Quantity 91 -0.1%
Value US$635
3.2
White Ted PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
6.98
Quantity 154 -0.1%
Value US$1,075
3.5
Goldenberg Gary Chief Medical Officer Officer
Transaction date
Sale
Price
7.06
Quantity 18,421 -14.6%
Value US$130,052
3.8
Bonaccorso Joe CHIEF COMMERCIAL OFFICER Officer
Transaction date
Sale
Price
7.06
Quantity 25,461 -19.2%
Value US$179,755
3.4
Hayes Christopher G. CHIEF LEGAL OFFICER Officer
Transaction date
Sale
Price
7.06
Quantity 21,649 -13.3%
Value US$152,842
3.2
White Ted PRESIDENT AND CEO Executive Director
Transaction date
Sale
Price
7.06
Quantity 32,469 -11.5%
Value US$229,231
3.2
White Ted Officer Officer
Transaction date
Proposed sale
Price
6.97
Quantity 32,953
Value US$229,628
3.5
Goldenberg Gary Officer Officer
Transaction date
Proposed sale
Price
6.97
Quantity 18,695
Value US$130,253
3.4
Hayes Christopher G. Officer Officer
Transaction date
Proposed sale
Price
6.97
Quantity 21,971
Value US$153,085
3.8
Bonaccorso Joe Officer Officer
Transaction date
Proposed sale
Price
6.97
Quantity 25,840
Value US$180,048
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
7.24
Quantity 115,774 +1.7%
Value US$838,204
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
7.08
Quantity 126,116 +1.8%
Value US$892,901
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
7.20
Quantity 79,726 +1.2%
Value US$574,027
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
6.49
Quantity 54,652 +0.8%
Value US$354,691
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
6.67
Quantity 250,000 +3.9%
Value US$1,667,500
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
6.17
Quantity 200,000 +3.2%
Value US$1,234,000
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
5.36
Quantity 277,008 +4.6%
Value US$1,484,763
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
5.41
Quantity 456,923 +8.2%
Value US$2,471,953
2.7
PERCEPTIVE ADVISORS LLC Large shareholder
Transaction date
Purchase
Price
5.97
Quantity 500,000 +9.9%
Value US$2,985,000
3.8
Bonaccorso Joe Chief Commercial Officer Officer
Transaction date
Sale
Price
2.97
Quantity 11,266 -10.9%
Value US$33,460
3.2
White Ted President and CEO Executive Director
Transaction date
Sale
Price
2.97
Quantity 11,558 -6.4%
Value US$34,327
2.0
Kohler Terry Chief Financial Officer Officer
Transaction date
Sale
Price
2.97
Quantity 9,632 -21.9%
Value US$28,607
3.5
Goldenberg Gary Chief Medical Officer Officer
Transaction date
Sale
Price
2.97
Quantity 3,036 -3.4%
Value US$9,017
3.4
Hayes Christopher G. Chief Legal Officer Officer
Transaction date
Sale
Price
2.97
Quantity 11,558 -8.6%
Value US$34,327
3.8
Bonaccorso Joe Officer Officer
Transaction date
Proposed sale
Price
2.93
Quantity 32,943
Value US$96,522
3.8
Bonaccorso Joe Chief Commercial Officer Officer
Transaction date
Sale
Price
2.93
Quantity 21,580 -17.2%
Value US$63,229
3.2
White Ted President and CEO Executive Director
Transaction date
Sale
Price
2.93
Quantity 22,141 -10.9%
Value US$64,873
2.0
Kohler Terry Chief Financial Officer Officer
Transaction date
Sale
Price
2.93
Quantity 18,452 -29.5%
Value US$54,064
3.5
Goldenberg Gary Chief Medical Officer Officer
Transaction date
Sale
Price
2.93
Quantity 5,817 -6.1%
Value US$17,044
3.4
Hayes Christopher G. Chief Legal Officer Officer
Transaction date
Sale
Price
2.93
Quantity 22,141 -14.1%
Value US$64,873
2.0
Kohler Terry Officer Officer
Transaction date
Proposed sale
Price
2.93
Quantity 28,167
Value US$82,529
3.4
Hayes Christopher G. Officer Officer
Transaction date
Proposed sale
Price
2.93
Quantity 33,798
Value US$99,028
3.5
Goldenberg Gary Officer Officer
Transaction date
Proposed sale
Price
2.93
Quantity 8,879
Value US$26,015
3.2
White Ted Officer; Director Executive Director
Transaction date
Proposed sale
Price
2.93
Quantity 33,798
Value US$99,028
3.8
Bonaccorso Joe Officer Officer
Transaction date
Proposed sale
Price
2.93
Quantity 32,943
Value US$96,522
3.5
Goldenberg Gary Officer Officer
Transaction date
Proposed sale
Price
4.80
Quantity 28,699
Value US$137,837
3.2
White Ted Officer; Director Executive Director
Transaction date
Proposed sale
Price
4.80
Quantity 50,677
Value US$243,398
3.4
Hayes Christopher G. Officer Officer
Transaction date
Proposed sale
Price
4.80
Quantity 33,789
Value US$162,285
3.8
Bonaccorso Joe Officer Officer
Transaction date
Proposed sale
Price
4.80
Quantity 38,262
Value US$183,769
3.2
White Ted President and CEO Executive Director
Transaction date
Sale
Price
4.83
Quantity 50,677 -28.2%
Value US$244,770
3.5
Goldenberg Gary Chief Medical Officer Officer
Transaction date
Sale
Price
4.83
Quantity 28,699 -29.0%
Value US$138,616
3.8
Bonaccorso Joe Chief Commercial Officer Officer
Transaction date
Sale
Price
4.83
Quantity 38,262 -37.9%
Value US$184,805
3.4
Hayes Christopher G. Chief Legal Officer Officer
Transaction date
Sale
Price
4.83
Quantity 33,789 -29.2%
Value US$163,201
3.9
Manning Paul B Non-Executive Director Large shareholder
Transaction date
Purchase
Price
5.02
Quantity 200,000 +2.6%
Value US$1,004,000
3.4
Hayes Christopher G. Chief Legal Officer Officer
Transaction date
Purchase
Price
3.40
Quantity 7,500 +91.3%
Value US$25,500
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-18 2026-08-18 B Purchase
1.0
Kirby John J.

Interim CFO

Officer
53,630 -47.6%
133.11
US$1,315,214 		53,630 -47.6% 133.11 US$1,315,214
2026-08-18 2026-08-18 B Purchase
1.7
Rosenberg Noah L.

CMO

Officer
81,216 -37.2%
213.59
US$664,719 		81,216 -37.2% 213.59 US$664,719
2026-08-18 2026-08-17 B Purchase
Rieger Jayson

CEO and President

Executive Director
82,006 -27.0%
467.03
US$942,020 		82,006 -27.0% 467.03 US$942,020
2026-08-18 2026-08-17 B Purchase
1.7
Rosenberg Noah L.

CMO

Officer
4,200 +178.2%
4.91
US$20,622 		4,200 +178.2% 4.91 US$20,622
2026-08-18 2026-08-17 B Purchase
Zawitz David

Chief Operating Officer

Officer
6,000 +28.6%
4.98
US$29,880 		6,000 +28.6% 4.98 US$29,880
2026-08-18 2026-08-14 B Purchase
Rieger Jayson

CEO and President

Executive Director
20,000 +11.0%
5.06
US$101,200 		20,000 +11.0% 5.06 US$101,200
2025-11-25 2025-11-25 B Purchase
Zawitz David

Chief Operating Officer

Officer
10,000 +90.9%
4.24
US$42,425 		10,000 +90.9% 4.24 US$42,425
2025-11-25 2025-11-25 B Purchase
3.9
Manning Paul B
Non-Executive Director Large shareholder
2,750,762 +460.3%
4.24
US$11,670,108 		2,750,762 +460.3% 4.24 US$11,670,108
2025-11-25 2025-11-25 B Purchase
3.9
Manning Paul B
Non-Executive Director Large shareholder
1,375,380 +53.3%
4.24
US$5,835,050 		1,375,380 +53.3% 4.24 US$5,835,050
2025-11-25 2025-11-25 B Purchase
Rieger Jayson

CEO and President

Executive Director
94,311 +106.8%
4.24
US$400,114 		94,311 +106.8% 4.24 US$400,114
2025-11-25 2025-11-25 B Purchase
1.0
Kirby John J.

Interim CFO

Officer
3,536 +65.2%
4.24
US$15,001 		3,536 +65.2% 4.24 US$15,001
2025-11-25 2025-11-25 B Purchase
1.7
Rosenberg Noah L.

CMO

Officer
2,357 +inf%
4.24
US$10,000 		2,357 +inf% 4.24 US$10,000
2025-03-18 2025-03-17 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
4,315 -2.4%
0.65
US$2,805 		4,315 -2.4% 0.65 US$2,805
2024-08-28 2024-08-27 S Sale
2.0
Kohler Terry

CHIEF FINANCIAL OFFICER

Officer
7,899 -15.0%
2.46
US$19,432 		7,899 -15.0% 2.46 US$19,432
2024-08-28 2024-08-27 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
3,601 -3.7%
2.46
US$8,858 		3,601 -3.7% 2.46 US$8,858
2024-08-28 2024-08-27 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
9,021 -4.0%
2.46
US$22,192 		9,021 -4.0% 2.46 US$22,192
2024-08-28 2024-08-27 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
9,530 -8.3%
2.46
US$23,444 		9,530 -8.3% 2.46 US$23,444
2024-08-28 2024-08-27 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
8,993 -11.0%
2.46
US$22,123 		8,993 -11.0% 2.46 US$22,123
2024-08-28 2024-08-26 S Sale
2.0
Kohler Terry

CHIEF FINANCIAL OFFICER

Officer
21,820 -29.3%
2.66
US$58,041 		21,820 -29.3% 2.66 US$58,041
2024-08-28 2024-08-26 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
9,888 -9.2%
2.66
US$26,302 		9,888 -9.2% 2.66 US$26,302
2024-08-28 2024-08-26 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
24,979 -10.0%
2.66
US$66,444 		24,979 -10.0% 2.66 US$66,444
2024-08-28 2024-08-26 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
26,183 -18.5%
2.66
US$69,647 		26,183 -18.5% 2.66 US$69,647
2024-08-28 2024-08-26 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
24,709 -23.1%
2.66
US$65,726 		24,709 -23.1% 2.66 US$65,726
2024-08-26 2024-08-26 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
36,000
2.62
US$94,300 		36,000 2.62 US$94,300
2024-08-26 2024-08-26 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
14,000
2.64
US$37,000 		14,000 2.64 US$37,000
2024-08-26 2024-08-26 PrS Proposed sale
3.2
White Ted

Officer

Officer
34,000
2.65
US$90,100 		34,000 2.65 US$90,100
2024-08-26 2024-08-26 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
34,000
2.65
US$90,100 		34,000 2.65 US$90,100
2024-08-26 2024-08-26 PrS Proposed sale
2.0
Kohler Terry

Officer

Officer
30,000
2.65
US$79,500 		30,000 2.65 US$79,500
2024-07-23 2024-07-23 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
86 -0.1%
6.98
US$600 		86 -0.1% 6.98 US$600
2024-07-23 2024-07-23 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
115 -0.1%
6.98
US$803 		115 -0.1% 6.98 US$803
2024-07-23 2024-07-23 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
91 -0.1%
6.98
US$635 		91 -0.1% 6.98 US$635
2024-07-23 2024-07-23 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
154 -0.1%
6.98
US$1,075 		154 -0.1% 6.98 US$1,075
2024-07-23 2024-07-22 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
18,421 -14.6%
7.06
US$130,052 		18,421 -14.6% 7.06 US$130,052
2024-07-23 2024-07-22 S Sale
3.8
Bonaccorso Joe

CHIEF COMMERCIAL OFFICER

Officer
25,461 -19.2%
7.06
US$179,755 		25,461 -19.2% 7.06 US$179,755
2024-07-23 2024-07-22 S Sale
3.4
Hayes Christopher G.

CHIEF LEGAL OFFICER

Officer
21,649 -13.3%
7.06
US$152,842 		21,649 -13.3% 7.06 US$152,842
2024-07-23 2024-07-22 S Sale
3.2
White Ted

PRESIDENT AND CEO

Executive Director
32,469 -11.5%
7.06
US$229,231 		32,469 -11.5% 7.06 US$229,231
2024-07-22 2024-07-22 PrS Proposed sale
3.2
White Ted

Officer

Officer
32,953
6.97
US$229,628 		32,953 6.97 US$229,628
2024-07-22 2024-07-22 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
18,695
6.97
US$130,253 		18,695 6.97 US$130,253
2024-07-22 2024-07-22 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
21,971
6.97
US$153,085 		21,971 6.97 US$153,085
2024-07-22 2024-07-22 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
25,840
6.97
US$180,048 		25,840 6.97 US$180,048
2023-12-29 2023-12-29 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
115,774 +1.7%
7.24
US$838,204 		115,774 +1.7% 7.24 US$838,204
2023-12-29 2023-12-28 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
126,116 +1.8%
7.08
US$892,901 		126,116 +1.8% 7.08 US$892,901
2023-12-29 2023-12-27 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
79,726 +1.2%
7.20
US$574,027 		79,726 +1.2% 7.20 US$574,027
2023-12-26 2023-12-26 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
54,652 +0.8%
6.49
US$354,691 		54,652 +0.8% 6.49 US$354,691
2023-12-26 2023-12-22 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
250,000 +3.9%
6.67
US$1,667,500 		250,000 +3.9% 6.67 US$1,667,500
2023-12-26 2023-12-21 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
200,000 +3.2%
6.17
US$1,234,000 		200,000 +3.2% 6.17 US$1,234,000
2023-12-19 2023-12-19 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
277,008 +4.6%
5.36
US$1,484,763 		277,008 +4.6% 5.36 US$1,484,763
2023-12-19 2023-12-18 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
456,923 +8.2%
5.41
US$2,471,953 		456,923 +8.2% 5.41 US$2,471,953
2023-12-19 2023-12-15 B Purchase
2.7
PERCEPTIVE ADVISORS LLC
Large shareholder
500,000 +9.9%
5.97
US$2,985,000 		500,000 +9.9% 5.97 US$2,985,000
2023-11-16 2023-11-15 S Sale
3.8
Bonaccorso Joe

Chief Commercial Officer

Officer
11,266 -10.9%
2.97
US$33,460 		11,266 -10.9% 2.97 US$33,460
2023-11-16 2023-11-15 S Sale
3.2
White Ted

President and CEO

Executive Director
11,558 -6.4%
2.97
US$34,327 		11,558 -6.4% 2.97 US$34,327
2023-11-16 2023-11-15 S Sale
2.0
Kohler Terry

Chief Financial Officer

Officer
9,632 -21.9%
2.97
US$28,607 		9,632 -21.9% 2.97 US$28,607
2023-11-16 2023-11-15 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
3,036 -3.4%
2.97
US$9,017 		3,036 -3.4% 2.97 US$9,017
2023-11-16 2023-11-15 S Sale
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
11,558 -8.6%
2.97
US$34,327 		11,558 -8.6% 2.97 US$34,327
2023-11-16 2023-11-14 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
32,943
2.93
US$96,522 		32,943 2.93 US$96,522
2023-11-16 2023-11-14 S Sale
3.8
Bonaccorso Joe

Chief Commercial Officer

Officer
21,580 -17.2%
2.93
US$63,229 		21,580 -17.2% 2.93 US$63,229
2023-11-16 2023-11-14 S Sale
3.2
White Ted

President and CEO

Executive Director
22,141 -10.9%
2.93
US$64,873 		22,141 -10.9% 2.93 US$64,873
2023-11-16 2023-11-14 S Sale
2.0
Kohler Terry

Chief Financial Officer

Officer
18,452 -29.5%
2.93
US$54,064 		18,452 -29.5% 2.93 US$54,064
2023-11-16 2023-11-14 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
5,817 -6.1%
2.93
US$17,044 		5,817 -6.1% 2.93 US$17,044
2023-11-16 2023-11-14 S Sale
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
22,141 -14.1%
2.93
US$64,873 		22,141 -14.1% 2.93 US$64,873
2023-11-15 2023-11-14 PrS Proposed sale
2.0
Kohler Terry

Officer

Officer
28,167
2.93
US$82,529 		28,167 2.93 US$82,529
2023-11-15 2023-11-14 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
33,798
2.93
US$99,028 		33,798 2.93 US$99,028
2023-11-15 2023-11-14 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
8,879
2.93
US$26,015 		8,879 2.93 US$26,015
2023-11-15 2023-11-14 PrS Proposed sale
3.2
White Ted

Officer; Director

Executive Director
33,798
2.93
US$99,028 		33,798 2.93 US$99,028
2023-11-15 2023-11-14 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
32,943
2.93
US$96,522 		32,943 2.93 US$96,522
2023-07-27 2023-07-24 PrS Proposed sale
3.5
Goldenberg Gary

Officer

Officer
28,699
4.80
US$137,837 		28,699 4.80 US$137,837
2023-07-27 2023-07-24 PrS Proposed sale
3.2
White Ted

Officer; Director

Executive Director
50,677
4.80
US$243,398 		50,677 4.80 US$243,398
2023-07-27 2023-07-24 PrS Proposed sale
3.4
Hayes Christopher G.

Officer

Officer
33,789
4.80
US$162,285 		33,789 4.80 US$162,285
2023-07-27 2023-07-24 PrS Proposed sale
3.8
Bonaccorso Joe

Officer

Officer
38,262
4.80
US$183,769 		38,262 4.80 US$183,769
2023-07-25 2023-07-24 S Sale
3.2
White Ted

President and CEO

Executive Director
50,677 -28.2%
4.83
US$244,770 		50,677 -28.2% 4.83 US$244,770
2023-07-25 2023-07-24 S Sale
3.5
Goldenberg Gary

Chief Medical Officer

Officer
28,699 -29.0%
4.83
US$138,616 		28,699 -29.0% 4.83 US$138,616
2023-07-25 2023-07-24 S Sale
3.8
Bonaccorso Joe

Chief Commercial Officer

Officer
38,262 -37.9%
4.83
US$184,805 		38,262 -37.9% 4.83 US$184,805
2023-07-25 2023-07-24 S Sale
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
33,789 -29.2%
4.83
US$163,201 		33,789 -29.2% 4.83 US$163,201
2023-07-24 2023-07-24 B Purchase
3.9
Manning Paul B
Non-Executive Director Large shareholder
200,000 +2.6%
5.02
US$1,004,000 		200,000 +2.6% 5.02 US$1,004,000
2022-07-11 2022-07-11 B Purchase
3.4
Hayes Christopher G.

Chief Legal Officer

Officer
7,500 +91.3%
3.40
US$25,500 		7,500 +91.3% 3.40 US$25,500
Explore more

More insider trading research around Verrica Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America